ArticleDiabetes, obesity & metabolism2026
Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nonalcoholic Fatty Liver Disease as a Risk Marker for Incident Type 2 Diabetes Mellitus: A Systematic Review.Cureus · 2026Review
- Associations of insulin resistance-related indices with the risk and progression of cardiometabolic multimorbidity in individuals with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.Cardiovascular diabetology · 2026Article
- Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsThe impact of steatotic liver disease (SLD) subtypes on incident type 2 diabetes remains unclear. We investigated the association of metabolic dysfunction-associated steatotic liver disease (MASLD), MetALD (MASLD with moderate alcohol consumption), and alcohol-related liver disease (ALD) with incident type 2 diabetes in Korean adults aged 20-39 years. MATERIALS AND
methodsUsing the Korean National Health Insurance Service database, we included 6 250 145 adults aged 20-39 who underwent health examinations between 2009 and 2012. SLD subtypes were classified by fatty liver index and alcohol intake. Incident type 2 diabetes was assessed using Cox proportional hazards models.
resultsDuring a median follow-up of 10.6 years, 72 028 participants developed type 2 diabetes. Incidence rates per 1000 person-years were higher in MASLD (10.56), MetALD (9.96), and ALD (12.49) than in non-SLD (1.29). Multivariable analyses showed significantly increased risks of type 2 diabetes (adjusted hazard ratios [95% CI]: 2.81 [2.78-2.85] for MASLD, 2.92 [2.87-2.98] for MetALD, and 3.99 [3.88-4.09] for ALD).
conclusionAll SLD subtypes significantly increased the risk of type 2 diabetes in young adults, with the greatest risk in ALD, followed by MetALD and MASLD. Early detection and management of SLD are essential to reduce the future burden of diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.